REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 35 filers reported holding REXAHN PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $11,000 | +266.7% | 21,500 | 0.0% | 0.00% | +200.0% |
Q4 2016 | $3,000 | -40.0% | 21,500 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $5,000 | 0.0% | 21,500 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $5,000 | -28.6% | 21,500 | 0.0% | 0.00% | -66.7% |
Q1 2016 | $7,000 | -12.5% | 21,500 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $8,000 | -27.3% | 21,500 | 0.0% | 0.00% | -40.0% |
Q3 2015 | $11,000 | -8.3% | 21,500 | +7.5% | 0.01% | +66.7% |
Q2 2015 | $12,000 | -20.0% | 20,000 | 0.0% | 0.00% | -50.0% |
Q1 2015 | $15,000 | -28.6% | 20,000 | -33.3% | 0.01% | -33.3% |
Q4 2014 | $21,000 | +162.5% | 30,000 | +200.0% | 0.01% | +125.0% |
Q3 2014 | $8,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Anson Funds Management LP | 18,340,000 | $3,852,000 | 0.41% |
SABBY MANAGEMENT, LLC | 9,464,849 | $1,988,000 | 0.07% |
Northeast Financial Consultants Inc | 150,000 | $31,000 | 0.01% |
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 200,000 | $42,000 | 0.01% |
TWO SIGMA SECURITIES, LLC | 185,239 | $39,000 | 0.01% |
Benin Management CORP | 93,000 | $20,000 | 0.01% |
CONDOR CAPITAL MANAGEMENT | 145,000 | $30,000 | 0.01% |
NIXON PEABODY TRUST CO | 10,000 | $2,000 | 0.00% |
Tower Research Capital LLC (TRC) | 47,677 | $10,000 | 0.00% |
Renaissance Technologies | 3,201,993 | $672,000 | 0.00% |